Thermo Fisher invests US$ 140 million to increase laboratory plastics production

Thermo Fisher Scientific is investing more than US$ 140 million (approximately Rs 1000 crore) to expand its laboratory plastics consumables production further to support significant global demand for Covid-19 testing, as well as development and manufacturing of therapies and vaccines. “Early in the pandemic, we quickly joined forces with governments, public health agencies and industry to increase capacity across our laboratory plastics production facilities and address the growing COVID-19 threat,” said Fred Lowery, senior vice president and president of Life Sciences Solutions and Laboratory Products at Thermo Fisher Scientific. “However, demand quickly exceeded those early expansion projects, so we began a series of additional expansions to meet the growing needs of our customers. These investments, along with many others across the company, will ensure that our customers have the supplies they need to continue meeting the unprecedented demands of the Covid-19 response.” Creating over 1,000 jobs The rapid increase in production related to Covid-19 testing, and development and manufacturing of therapies and vaccines, has created historic demand for laboratory plastics, including pipette and automation tips,…

Choose your subscription to read more